Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIG
The use of high dose chemotherapy followed by autologous hematopoietic stem cell transplantation for remission consolidation after initial induction represents standard of care for patients with multiple myeloma. Patients with myeloma and Acquired von Willebrand Syndrome (AVWS) undergoing autologous...
Saved in:
Main Authors: | Behyar Zoghi, Paul Shaughnessy, Roger M. Lyons, Richard Helmer, Carlos Bachier, C. Frederick LeMaistre |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2015/809313 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acquired von Willebrand Disease Associated with Monoclonal Gammopathy of Unknown Significance
by: Sijan Basnet, et al.
Published: (2017-01-01) -
Acquired von Willebrand Syndrome in IgM Monoclonal Gammopathy as the Presentation of Lymphoplasmacytic Lymphoma
by: Zachary Wolfe, et al.
Published: (2017-01-01) -
Two Rare Complications in One Patient: Acquired von Willebrand Syndrome Associated with Intracranial Plasmacytoma
by: H. Auge, et al.
Published: (2019-01-01) -
Challenges and considerations of genetic testing in von Willebrand disease
by: Omid Seidizadeh, et al.
Published: (2025-01-01) -
Global prevalence of platelet-type von Willebrand disease
by: Omid Seidizadeh, et al.
Published: (2025-01-01)